The pH-Insensitive Antimicrobial and Antibiofilm Activities of the Frog Skin Derived Peptide Esc(1-21): Promising Features for Novel Anti-Infective Drugs.

Maria Rosa Loffredo, Floriana Cappiello, Giacomo Cappella, Elisabetta Capuozzo, Luisa Torrini, Fabiana Diaco, Yuanpu Peter Di, Maria Luisa Mangoni, Bruno Casciaro
Author Information
  1. Maria Rosa Loffredo: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy. ORCID
  2. Floriana Cappiello: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy. ORCID
  3. Giacomo Cappella: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy. ORCID
  4. Elisabetta Capuozzo: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy. ORCID
  5. Luisa Torrini: Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  6. Fabiana Diaco: Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  7. Yuanpu Peter Di: Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. ORCID
  8. Maria Luisa Mangoni: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy. ORCID
  9. Bruno Casciaro: Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy. ORCID

Abstract

The number of antibiotic-resistant microbial infections is dramatically increasing, while the discovery of new antibiotics is significantly declining. Furthermore, the activity of antibiotics is negatively influenced by the ability of bacteria to form sessile communities, called biofilms, and by the microenvironment of the infection, characterized by an acidic pH, especially in the lungs of patients suffering from cystic fibrosis (CF). Antimicrobial peptides represent interesting alternatives to conventional antibiotics, and with expanding properties. Here, we explored the effects of an acidic pH on the antimicrobial and antibiofilm activities of the AMP Esc(1-21) and we found that it slightly lost activity (from 2- to 4-fold) against the planktonic form of a panel of Gram-negative bacteria, with respect to a ��� 32-fold of traditional antibiotics. Furthermore, it retained its activity against the sessile form of these bacteria grown in media with a neutral pH, and showed similar or higher effectiveness against the biofilm form of bacteria grown in acidic media, simulating a CF-like acidic microenvironment, compared to physiological conditions.

Keywords

References

  1. ACS Chem Biol. 2023 Oct 20;18(10):2128-2143 [PMID: 37730207]
  2. Protein Pept Lett. 2018;25(12):1155-1162 [PMID: 30381056]
  3. Front Cell Infect Microbiol. 2023 Nov 15;13:1294082 [PMID: 38035341]
  4. Front Microbiol. 2021 Nov 19;12:747834 [PMID: 34867864]
  5. PLoS Med. 2023 Jul 3;20(7):e1004264 [PMID: 37399216]
  6. Urology. 2014 Sep;84(3):731.e1-7 [PMID: 25168568]
  7. Antibiotics (Basel). 2020 Jul 26;9(8): [PMID: 32722535]
  8. Antibiotics (Basel). 2022 Feb 11;11(2): [PMID: 35203836]
  9. Biofactors. 2024 Jan-Feb;50(1):201-213 [PMID: 37768028]
  10. Microbiol Spectr. 2023 Aug 17;11(4):e0483222 [PMID: 37278652]
  11. Front Biosci (Elite Ed). 2023 Dec 5;15(4):28 [PMID: 38163940]
  12. Antibiotics (Basel). 2024 Jan 11;13(1): [PMID: 38247630]
  13. Biochim Biophys Acta. 2016 May;1858(5):1044-60 [PMID: 26525663]
  14. Int J Mol Sci. 2024 Apr 29;25(9): [PMID: 38732089]
  15. Anal Biochem. 1980 May 1;104(1):10-4 [PMID: 6892980]
  16. Biochim Biophys Acta Biomembr. 2017 Dec;1859(12):2327-2339 [PMID: 28912103]
  17. Pharmaceutics. 2022 Oct 26;14(11): [PMID: 36365116]
  18. Front Microbiol. 2018 Nov 20;9:2657 [PMID: 30515135]
  19. J Mol Microbiol Biotechnol. 2007;13(1-3):1-11 [PMID: 17693707]
  20. Cell Mol Life Sci. 2013 Aug;70(15):2773-86 [PMID: 23503622]
  21. J Paediatr Child Health. 2021 Jul;57(7):1148-1149 [PMID: 33929764]
  22. Microorganisms. 2023 Mar 28;11(4): [PMID: 37110286]
  23. Biotechnol Genet Eng Rev. 2023 Apr 10;:1-39 [PMID: 37036043]
  24. Epidemiol Infect. 2018 Mar;146(4):524-530 [PMID: 29283077]
  25. Amino Acids. 2015 Dec;47(12):2505-19 [PMID: 26162435]
  26. Folia Microbiol (Praha). 2010 Jan;55(1):75-8 [PMID: 20336508]
  27. Cureus. 2024 Apr 13;16(4):e58178 [PMID: 38741875]
  28. Nat Rev Microbiol. 2011 May;9(5):330-43 [PMID: 21464825]
  29. Bioorg Chem. 2024 Apr;145:107151 [PMID: 38359706]
  30. Infection. 2005 Dec;33 Suppl 2:36-43 [PMID: 16518710]
  31. Eur J Cell Biol. 2018 Aug;97(6):402-410 [PMID: 29933921]
  32. Amino Acids. 2017 Jan;49(1):139-150 [PMID: 27726008]
  33. JAAPA. 2017 May;30(5):23-27 [PMID: 28441669]
  34. Sci Rep. 2017 Jul 31;7(1):6953 [PMID: 28761101]
  35. Front Med (Lausanne). 2021 Jul 30;8:650637 [PMID: 34395460]
  36. Int J Mol Sci. 2021 Jan 08;22(2): [PMID: 33429882]
  37. Front Microbiol. 2020 Sep 24;11:556140 [PMID: 33117305]
  38. Science. 2016 Jan 29;351(6272):503-7 [PMID: 26823428]
  39. Int J Mol Sci. 2021 Apr 10;22(8): [PMID: 33920239]
  40. Microbiol Res. 2021 Oct;251:126829 [PMID: 34332222]
  41. Eur Respir Rev. 2021 Sep 15;30(161): [PMID: 34526313]
  42. Int Wound J. 2012 Aug;9(4):428-35 [PMID: 22182197]
  43. Antibiotics (Basel). 2022 May 13;11(5): [PMID: 35625300]
  44. Biochim Biophys Acta Biomembr. 2018 Nov;1860(11):2374-2384 [PMID: 29885294]
  45. Sci Rep. 2019 Apr 24;9(1):6516 [PMID: 31019198]
  46. Biofilm. 2022 Oct 22;4:100089 [PMID: 36324525]
  47. Antibiotics (Basel). 2023 Jan 20;12(2): [PMID: 36830128]
  48. J Nat Prod. 2024 Mar 22;87(3):600-616 [PMID: 38412091]
  49. Microbiol Spectr. 2015 Jun;3(3): [PMID: 26185074]
  50. Eur Respir J. 2003 Jan;21(1):37-42 [PMID: 12570106]
  51. Biopolymers. 2017 Oct 31;: [PMID: 29086910]
  52. Br J Biomed Sci. 2007;64(3):101-4 [PMID: 17910277]
  53. Drug Resist Updat. 2023 May;68:100954 [PMID: 36905712]
  54. EBioMedicine. 2021 Nov;73:103652 [PMID: 34740109]
  55. Biochim Biophys Acta. 2016 May;1858(5):1061-9 [PMID: 26724202]
  56. Curr Med Chem. 2020;27(9):1405-1419 [PMID: 31333082]
  57. Appl Microbiol Biotechnol. 2020 Jan;104(1):51-65 [PMID: 31773206]
  58. Pharmaceuticals (Basel). 2016 Nov 01;9(4): [PMID: 27809281]
  59. Int J Mol Med. 2018 Aug;42(2):831-838 [PMID: 29767263]
  60. Front Microbiol. 2018 Nov 15;9:2869 [PMID: 30498489]
  61. Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):182984 [PMID: 31075228]
  62. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):16083-8 [PMID: 14668433]
  63. J Med Chem. 2022 Apr 14;65(7):5355-5373 [PMID: 35294199]
  64. Nature. 2012 Jul 04;487(7405):109-13 [PMID: 22763554]
  65. ACS Appl Bio Mater. 2024 Apr 15;7(4):2023-2035 [PMID: 38533844]
  66. J Antimicrob Chemother. 2024 Jan 3;79(1):166-171 [PMID: 38000090]
  67. Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18703-8 [PMID: 25512526]
  68. Antibiotics (Basel). 2021 Nov 23;10(12): [PMID: 34943643]
  69. Am J Respir Crit Care Med. 2009 Jul 15;180(2):138-45 [PMID: 19423715]
  70. Antibiotics (Basel). 2020 Feb 03;9(2): [PMID: 32028684]

Grants

  1. Project FFC#4/2022. Delegazione FFC Ricerca di Roma e della Franciacorta e Val Camonica/Fondazione Italiana per la Ricerca sulla Fibrosi Cistica
  2. Project no. PE00000007, INF-ACT/NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
  3. RP122181619F624E/Sapienza University of Rome
  4. R01 AI176537/NIAID NIH HHS
  5. RM1221815DABA9B4/Sapienza University of Rome

Word Cloud

Similar Articles

Cited By